HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.58B |
| 2 |
Pinduoduo
PDD
|
+$483M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$380M |
| 4 |
MarketAxess Holdings
MKTX
|
+$340M |
| 5 |
Oracle
ORCL
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$684M |
| 2 |
NVIDIA
NVDA
|
+$510M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$316M |
| 5 |
UnitedHealth
UNH
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.32% |
| 2 | Financials | 12.35% |
| 3 | Consumer Discretionary | 11.08% |
| 4 | Communication Services | 8.95% |
| 5 | Healthcare | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Collegium Pharmaceutical
COLL
$1.16B
| $613K | ﹤0.01% |
17,334
+2,809
| +19% | +$97.6K |
|
2002
Materion
MTRN
$4.41B
| $612K | ﹤0.01% |
5,140
+1,289
| +33% | +$135K |
|
2003
LendingTree
TREE
$456M
| $610K | ﹤0.01% |
9,424
-4,654
| -33% | -$268K |
|
2004
Warby Parker
WRBY
$3.47B
| $610K | ﹤0.01% |
22,408
-1,751
| -7% | -$44.2K |
|
2005
Otter Tail
OTTR
$3.8B
| $608K | ﹤0.01% |
7,407
+659
| +10% | +$53.4K |
|
2006
Zillow
ZG
$8.07B
| $606K | ﹤0.01% |
8,135
-205
| -2% | -$16.1K |
|
2007
PUT
PENN Entertainment
PENN
$2.71B
| $605K | ﹤0.01% |
31,400
| – | – |
|
2008
CRISPR Therapeutics
CRSP
$4.85B
| $605K | ﹤0.01% |
9,606
+4,325
| +82% | +$248K |
|
|
HTB
2009
HomeTrust Bancshares
HTB
$862M
| $604K | ﹤0.01% |
14,769
+15
| +0.1% | +$600 |
|
2010
Oak Valley Bancorp
OVLY
$284M
| $604K | ﹤0.01% |
21,375
+6,338
| +42% | +$178K |
|
2011
Transportadora de Gas del Sur
TGS
$4.7B
| $601K | ﹤0.01% |
28,262
+1,405
| +5% | +$36.3K |
|
2012
Azenta
AZTA
$1.35B
| $600K | ﹤0.01% |
+21,126
| New | +$655K |
|
2013
Global E Online
GLBE
$6.77B
| $596K | ﹤0.01% |
16,694
+9,495
| +132% | +$324K |
|
|
CPRX
2014
DELISTED
Catalyst Pharmaceutical
CPRX
| $595K | ﹤0.01% |
30,190
-21,632
| -42% | -$445K |
|
2015
Praxis Precision Medicines
PRAX
$8.4B
| $595K | ﹤0.01% |
+11,172
| New | +$542K |
|
2016
Kymera Therapeutics
KYMR
$8.46B
| $593K | ﹤0.01% |
10,314
+3,120
| +43% | +$141K |
|
2017
Midland States Bancorp
MSBI
$712M
| $592K | ﹤0.01% |
34,832
+1,666
| +5% | +$29.9K |
|
2018
Alight
ALIT
$495M
| $592K | ﹤0.01% |
9,062
-2,759
| -23% | -$244K |
|
|
ATXS
2019
DELISTED
Astria Therapeutics
ATXS
| $590K | ﹤0.01% |
81,183
+20,332
| +33% | +$138K |
|
2020
Atea Pharmaceuticals
AVIR
$374M
| $590K | ﹤0.01% |
206,359
+10,577
| +5% | +$36.1K |
|
2021
Alpha Metallurgical Resources
AMR
$1.71B
| $590K | ﹤0.01% |
3,615
-4,384
| -55% | -$608K |
|
2022
STMicroelectronics
STM
$45.9B
| $589K | ﹤0.01% |
21,095
-2,225
| -10% | -$62.2K |
|
2023
AXIS Capital
AXS
$7.77B
| $589K | ﹤0.01% |
6,157
+3,173
| +106% | +$307K |
|
2024
Addus HomeCare
ADUS
$2.18B
| $587K | ﹤0.01% |
4,990
-3,302
| -40% | -$370K |
|
2025
Polaris
PII
$4.06B
| $587K | ﹤0.01% |
+10,136
| New | +$547K |
|
Similar funds
HSBC Holdings's Q3 2025 Portfolio in Review
As of Q3 2025, HSBC Holdings held 3,226 positions worth $181B, up 8.9% from $167B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
HSBC Holdings's Q3 2025 filing shows 223 new, 1,147 increased, 1,166 reduced and 541 closed positions. Its largest new stake was iShares MSCI Italy ETF: 3,162,677 shares worth $164M. The largest sale was TSMC, an estimated $684M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
- HSBC Holdings's largest Q3 2025 buy was iShares MSCI Italy ETF: 3,162,677 shares worth $164M.
- HSBC Holdings added most to Microsoft in Q3 2025, an estimated $1.58B increase.
- HSBC Holdings's biggest Q3 2025 reduction was TSMC, cutting an estimated $684M.
- HSBC Holdings fully exited Juniper Networks in Q3 2025, selling an estimated $163M.
- HSBC Holdings's ten largest holdings make up 33% of its $181B portfolio in Q3 2025.
- HSBC Holdings opened 223 new positions and closed 541 in Q3 2025.
- HSBC Holdings's portfolio value rose 8.9% quarter-over-quarter to $181B.
Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.